Project Grant R01DK137942
Award Date
9/5/24
Completion Date
7/31/28
Dollars Obligated
$806K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
The Project Grant award R01DK140159 titled "RESOLUTION OF NONALCOHOLIC FATTY LIVER AND NONALCOHOLIC STEATOHEPATITIS BY A NOVEL ADIPOKINE" is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $469,235 award, effective from Sep 1, 2024 to Jun 30, 2028, supports research conducted by the University of Massachusetts Medical School (UMass Medical) to...
This federal Project Grant award in the amount of $172,140.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports research conducted by Dr. Jesse Platt, a physician-scientist at the Massachusetts General Hospital, to investigate the role of insulin receptor condensates in insulin resistance and associated diseases such as type 2 diabetes,...
This Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to understand the role of the unfolded protein response (UPR) in the pathogenesis of non-alcoholic steatohepatitis (NASH). The $172,060 award to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), aims to elucidate the mechanism of UPR...
This $409,375.00 Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research to understand the contribution of hepatic fatty acid oxidation to systemic metabolic dysfunction. The Johns Hopkins University will leverage genetic mouse models to investigate the role of fatty acid oxidation in regulating hepatic and systemic...
This $659,199 Project Grant awarded on February 25, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research at the University of Pittsburgh to investigate a novel signaling pathway by which the protein GDF15 can improve obesity-associated insulin resistance independent of body weight changes. The research aims to determine if hepatocyte-derived GDF15 can...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to elucidate the role of the BNIP3 protein in regulating lipid homeostasis in the liver. The $243,590 award, effective from Aug 14, 2024 to Mar 31, 2026, will allow the University of Chicago to investigate how BNIP3 mediates mitophagy and lipophagy in pericentral hepatocytes to...
This $174,128 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to discover the consequences of genetic variation in nephrin on kidney diseases and traits in biobank populations. The award was granted to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric medical research and...
The federal Project Grant award R56DK135533 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $599,541 award aims to define the role of antigen-specific T cell responses in non-alcoholic steatohepatitis (NASH), a chronic liver disease. The research seeks to: (1) determine the timing of T cell clonal expansion in the liver during NASH progression, (2)...
The federal Project Grant award F32DK139657, totaling $147,656.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award aims to advance the understanding of how fetal growth restriction (FGR) promotes fibrosis in the fetal liver, which can lead to increased risk of metabolic dysfunction-associated steatotic liver disease in children and adults born...
This $707,389 federal Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund a longitudinal study to evaluate the influence of nonalcoholic fatty liver disease (NAFLD) in pregnancy on women's health outcomes. The Icahn School of Medicine at Mount Sinai will prospectively screen 1,540 pregnant individuals for NAFLD and enroll them for...